Decipher: genomic sequencing classifier
Active Awarded Last action
- Contract number
- 36C24826F0044
- Awardee
-
Veracyte Labs SD Corporation UEI DKKCNLTYT2A1 Part of Veracyte, Inc.
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $324,059
Award facts
- Contract value 20% obligated
-
- $324,059.00 Current, with exercised options
- $1,620,295.00 Potential, with all options
- Completion date 18% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bay Pines, FL 33744, USA
Award details come from SAM.gov/FPDS.
About this award
Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., was awarded a delivery order valued at $1.62M by Veterans Integrated Service Network 8 on December 1, 2025, for genomic sequencing classifier services under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract, which carries a firm fixed price and no set-aside designation, extends through November 30, 2030, with performance taking place at Bay Pines, Florida. This delivery order leverages Veracyte's established blanket purchase agreement with VISN 8 valued at $972,177 and reflects the company's specialized capabilities in precision cancer diagnostics, particularly its proprietary Decipher Prostate Cancer Test for analyzing tumor gene expression patterns.
The Department of Veterans Affairs' Veterans Integrated Service Network 8, which serves veterans across the Gulf Coast region, continues to utilize Veracyte's advanced molecular diagnostic services to support precision medicine initiatives within its healthcare systems. This award demonstrates the ongoing partnership between the VA and Veracyte for providing genomic testing that enables clinicians to assess cancer risk and aggressiveness, supporting more informed treatment decision-making for veteran populations. Veracyte maintains similar contract vehicles across multiple VISN regions and the Defense Health Agency, positioning itself as a key provider of specialized genomic testing services throughout the federal healthcare sector.
Quick answers
Who was awarded contract 36C24826F0044?
36C24826F0044 was awarded to Veracyte Labs SD Corporation by Veterans Integrated Service Network 8 (Veterans Health Administration) on December 1, 2025.
How much is contract 36C24826F0044 worth?
The government has obligated $324,059 on 36C24826F0044. Its potential value, with all options, is $1,620,295.
Is contract 36C24826F0044 an order under another contract?
Yes. 36C24826F0044 is a delivery order under 36F79721D0019, a federal supply schedule, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C24826F0044 competed?
The extent of competition for 36C24826F0044 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award